Tag: renin-angiotensin system

HF Med Undertreatment Due to Older Age Common, Flouts Evidence

Advanced age by itself can be a reason physicians hold back on prescribing mainstay medications, or not uptitrate them per guidelines, to their older patients...

FDA Expands Sacubitril/Valsartan Indication to Embrace Some HFpEF

The US Food and Drug Administration (FDA) has approved a groundbreaking expanded indication for sacubitril/valsartan (Entresto), making it the first drug in the United States...

FDA Panel Supports Expanded HF Role for Sacubitril/Valsartan

A panel of federal advisers on Tuesday effectively backed a bid to expand approval of sacubitril/valsartan for use in a form of heart failure for...

Evidence of Possible RAS-Blocker Benefit in Patients With COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Patients infected by the COVID-19 virus may benefit from treatments that...

Stay on Angiotensin Drugs’ Still the Message as Trials Begin

What your doctor is reading on Medscape.com: APRIL 06, 2020 — Much remains unknown about the novel coronavirus SARS-CoV-2 and the disease it...

‘Stay on Angiotensin Drugs’ Still the Message as Trials Begin

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Much remains unknown about the novel coronavirus SARS-CoV-2 and the disease...